Advances in treatment of immune-related adverse reactions and hyperprogressive diseases associated with antitumor  immunotherapy with PD-1/PD-L1 monoclonal antibody drugs

WANG Pengyan, LIN Ziyou, ZHU Kai, ZHANG Xiaolei

PDF(2196 KB)
Chinese Journal of Pharmacology and Toxicology
PDF(2196 KB)
Chinese Journal of Pharmacology and Toxicology ›› 2024, Vol. 38 ›› Issue (1) : 56. DOI: 10.3867/j.issn.1000-3002.2024.01.007
REVIEWS

Advances in treatment of immune-related adverse reactions and hyperprogressive diseases associated with antitumor  immunotherapy with PD-1/PD-L1 monoclonal antibody drugs

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2024, 38(1): 56 https://doi.org/10.3867/j.issn.1000-3002.2024.01.007

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(2196 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉